drugset / Trial / NCT00713609

Safety and Efficacy Study of Clindamycin/Benzoyl Peroxide/Tazarotene Cream in Subjects With Acne

NCT00713609

Phase 2 Completed 591 enrolled Stiefel, a GSK Company GlaxoSmithKline · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Benzoyl peroxide, clindamycin and tazarotene are known to be effective treatment alternative for acne vulgaris. The purpose of this study is to assess the safety and efficacy of a combination product including these actives for the treatment of acne vulgaris. You may be suitable to take part in this study because you have acne vulgaris on your face. Acne vulgaris usually affects the face, but it can also affect the skin on the chest, arms, legs, and back.

Timeline

Start
2008-06
Primary completion
2009-03
Completion
2009-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Benzoyl Peroxide Other / unclassified 5 % Topical
Subject Clindamycin Unknown 1 % Topical
Subject Tazarotene Small molecule 0.1 % Topical

Indications